Skip to main content
Fig. 2 | Trials

Fig. 2

From: Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial

Fig. 2

SPIRIT figure of participant timelines. ANA antinuclear antibody, ACR American College of Rheumatology, AE adverse event, CLASI Cutaneous Lupus Erythematosus Disease Area and Severity Index, CSQ Connective Tissue Disease Screening Questionnaire, HCQ hydroxychloroquine, IFA immunofluorescence assay, SLEDAI Systemic Lupus Erythematosus Disease Activity Index, SLICC Systemic Lupus International Collaborating Clinics, SPIRIT Standard Protocol Items: Recommendations for Interventional Trials, Wk week

Back to article page